These results emphasized the potential significance of modulation of MFN2 and OPA1 in preventing mitochondrial dysfunction and lung cellular senescence in COPD, thus preventing the progress of COPD. The gene discussed is MFN2; the disease is chronic obstructive pulmonary disease.